Show simple item record

dc.contributor.authorEl-Asrar, Ahmed M. Abu
dc.contributor.authorNawaz, Mohd Imtiaz
dc.contributor.authorKangave, Dustan
dc.contributor.authorGeboes, Karel
dc.contributor.authorOla, Mohammad Shamsul
dc.contributor.authorAhmad, Saif
dc.contributor.authorAl-Shabrawey, Mohamed
dc.date.accessioned2012-10-26T20:27:56Z
dc.date.available2012-10-26T20:27:56Z
dc.date.issued2011-07-06en_US
dc.identifier.citationMol Vis. 2011 Jul 6; 17:1829-1838en_US
dc.identifier.issn1090-0535en_US
dc.identifier.pmid21850157en_US
dc.identifier.urihttp://hdl.handle.net/10675.2/749
dc.description.abstractPurpose: To measure levels of high-mobility group box −1 (HMGB1) and soluble receptor for advanced glycation end products (sRAGE) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR) and to correlate their levels with clinical disease activity and the levels of the inflammatory biomarkers monocyte chemoattractant protein-1 (MCP-1), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-1β (IL-1β), and granulocyte macrophage colony-stimulating factor (GM-CSF). In addition, we examined the expression of HMGB1 in the retinas of diabetic mice.
dc.description.abstractMethods: Vitreous samples from 29 PDR and 17 nondiabetic patients were studied by enzyme-linked immunosorbent assay. Retinas of mice were examined by immunofluorescence analysis and western blotting.
dc.description.abstractResults: HMGB1 was detected in all vitreous samples and sRAGE was detected in 5 PDR samples. IL-1β was detected in 3PDR samples and GM-CSF was not detected. Mean HMGB1 levels in PDR with active neovascularization were twofold and threefold higher than that in inactive PDR and nondiabetic patients, respectively. Mean HMGB1 levels in PDR patients with hemorrhage were significantly higher than those in PDR patients without hemorrhage and nondiabetic patients (p=0.0111). There were significant correlations between levels of HMGB1 and levels of MCP-1 (r=0.333, p=0.025) and sICAM-1 (r=0.548, p<0.001). HMGB1 expression was also upregulated in the retinas of diabetic mice.
dc.description.abstractConclusions: Subclinical chronic inflammation might contribute to the progression of PDR.
dc.rightsCopyright © 2011 Molecular Vision.en_US
dc.subjectResearch Articleen_US
dc.titleHigh-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathyen_US
dc.typeArticleen_US
dc.identifier.pmcidPMC3137555en_US
dc.contributor.corporatenameDepartment of Oral Biology
dc.contributor.corporatenameDepartment of Ophthalmology
refterms.dateFOA2019-04-10T00:46:30Z
html.description.abstractPurpose: To measure levels of high-mobility group box −1 (HMGB1) and soluble receptor for advanced glycation end products (sRAGE) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR) and to correlate their levels with clinical disease activity and the levels of the inflammatory biomarkers monocyte chemoattractant protein-1 (MCP-1), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-1β (IL-1β), and granulocyte macrophage colony-stimulating factor (GM-CSF). In addition, we examined the expression of HMGB1 in the retinas of diabetic mice.
html.description.abstractMethods: Vitreous samples from 29 PDR and 17 nondiabetic patients were studied by enzyme-linked immunosorbent assay. Retinas of mice were examined by immunofluorescence analysis and western blotting.
html.description.abstractResults: HMGB1 was detected in all vitreous samples and sRAGE was detected in 5 PDR samples. IL-1β was detected in 3PDR samples and GM-CSF was not detected. Mean HMGB1 levels in PDR with active neovascularization were twofold and threefold higher than that in inactive PDR and nondiabetic patients, respectively. Mean HMGB1 levels in PDR patients with hemorrhage were significantly higher than those in PDR patients without hemorrhage and nondiabetic patients (p=0.0111). There were significant correlations between levels of HMGB1 and levels of MCP-1 (r=0.333, p=0.025) and sICAM-1 (r=0.548, p<0.001). HMGB1 expression was also upregulated in the retinas of diabetic mice.
html.description.abstractConclusions: Subclinical chronic inflammation might contribute to the progression of PDR.


Files in this item

Thumbnail
Name:
mv-v17-1829.pdf
Size:
915.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record